| Literature DB >> 28989245 |
Sameh Soliman1,2, Dina Alnajdy1, Ali A El-Keblawy3, Kareem A Mosa3,4, Ghalia Khoder5, Ayman M Noreddin6,7.
Abstract
Candida is a serious life-threatening pathogen, particularly with immunocompromised patients. Candida infections are considered as a major cause of morbidity and mortality in a broad range of immunocompromised patients. Candida infections are common in hospitalized patients and elderly people. The difficulty to eradicate Candida infections is owing to its unique switch between yeast and hyphae forms and more likely to biofilm formations that render resistance to antifungal therapy. Plants are known sources of natural medicines. Several plants show significant anti-Candida activities and some of them have lower minimum inhibitory concentration, making them promising candidates for anti-Candida therapy. However, none of these plant products is marketed for anti-Candida therapy because of lack of sufficient information about their efficacy, toxicity, and kinetics. This review revises major plants that have been tested for anti-Candida activities with recommendations for further use of some of these plants for more investigation and in vivo testing including the use of nanostructure lipid system.Entities:
Keywords: Anti-Candida; Candida; biofilm; natural products; plants
Year: 2017 PMID: 28989245 PMCID: PMC5628516 DOI: 10.4103/phrev.phrev_8_17
Source DB: PubMed Journal: Pharmacogn Rev ISSN: 0973-6581
Candida resistance to synthetic drugs
Natural anti-Candida products, their botanical sources, and minimum inhibitory concentration
Figure 1Representative drawing of the active sites and mechanisms of most tested plant anti-Candida agents
Figure 2Simplified flow chart showing the utilization of different biotechnological approaches for identifying, developing, and enhancing the production levels of anti-Candida candidate compounds from a plant source